Innovation at Purdue news
If Stove Top stuffing makes an appearance at your Thanksgiving dinner, you can thank a Purdue University alumna.
The COVID-19 pandemic is leading a Purdue University innovator to make changes as she works to provide new options for people with Parkinson’s disease.
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
WEST LAFAYETTE, Ind. – New autonomous sensor technology may help businesses monitor refrigeration and heating systems in real time much faster and easier than current options.
Purdue University's Center for Education and Research in Information Assurance and Security (CERIAS) is joining the national Cybersecurity Manufacturing Innovation Institute (CyManII) to improve cybersecurity and energy efficiency for American manufacturing.
Beyond COVID-19: New technologies, treatments could help recovered survivors now facing neurological aftereffects
Globally about 50 million people have been diagnosed with COVID-19, 1.2 million have died from the virus and 36.5 million have recovered, according to the World Health Organization.
Parkinson’s patients use telehealth access for immediate speech improvement during COVID-19 pandemic
SpeechVive Inc. announced Thursday (Nov. 19) it is making its remote calibration software and training available free during the COVID-19 global health crisis. The software and training are available to all speech-language pathologists and their patients, as well as Veterans Affairs medical centers and veterans with Parkinson’s disease.